Transgenomic (TBIO) Reports Q1 Loss Per Share of $0.10
Tweet
Share
E-mailGet Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
Research and development: 393K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 393K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q1 EPS of ($0.10), versus ($0.28) reported last year.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
